Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniel Herrero Rivera"'
Autor:
Daniel Herrero Rivera, Carmen Garrigós Vacas, Laura Marcos Kovandzic, Javier Puente Vázquez, Lucía A Alonso, Begoña Mellado González, Verónica Calderero Aragón, Enrique Grande, Raquel Luque Caro, Juan A Virizuela Echaburu, Juan F Rodríguez Moreno, Ainara A Etxebarria, Cristina Rodríguez-Antona, Ignacio Durán
Publikováno v:
Pharmacogenomics. 23:627-638
[Background The aim of this study was to evaluate the impact of certain single-nucleotide polymorphisms (SNPs) in cabazitaxel activity and tox]icity in patients with metastatic castration-resistant prostate cancer (mCRPC).
[Patients & methods] 5
[Patients & methods] 5
Autor:
Oscar Reig Torras, Natalia Jiménez, Marta Garcia de Herreros, Caterina Aversa, Mercedes Marin, Laura Ferrer, Leonardo Rodriguez-Carunchio, Isabel Trias, Laia Fernandez-Mañas, Samuel García-Esteve, Albert Font Pous, Alejo Rodriguez-Vida, Montserrat Domenech-Santasusana, Mariona Figols, Miguel Ángel Climent, Sara Cros Costa, Isabel Chirivella, Daniel Herrero Rivera, Cristina Suárez, Begoña Mellado-Gonzalez
Publikováno v:
Journal of Clinical Oncology. 41:236-236
236 Background: Alterations on the tumor suppressor genes (TSG) RB1, PTEN and TP53 are associated with treatment resistance and aggressive clinical evolution of prostate cancer patients (pts). We developed and assessed the role of a TSG gene expressi
Autor:
María José Ortiz Gordillo, Eleonor Rivin del Campo, Gerardo Sanchez Carmona, Blas David Delgado León, María Valle Enguix-Riego, Jon Cacicedo, Jose María Nieto-Guerrero Gómez, Daniel Herrero Rivera, Marco Perez, Juan Manuel Praena-Fernández, Jose Luis Lopez Guerra
Publikováno v:
Radiotherapy and Oncology. 136:29-36
Background and purpose Definitive radiation therapy (RT) with or without chemotherapy has become the standard treatment for non-metastatic unresectable non-small cell lung cancer (NSCLC). However, treatment outcomes can differ substantially and patie
Autor:
Caterina Aversa, Natalia Jiménez, Mercedes Marin, Laura Ferrer-Mileo, Oscar Reig, Leonardo Rodriguez-Carunchio, Albert Font, Alejo Rodriguez-Vida, Montserrat Domenech-Santasusana, Mariona Figols, Miguel Angel Climent Duran, Sara Cros Costa, Isabel Chirivella, Daniel Herrero Rivera, Enrique Gonzalez -Billalabeitia, Daniel Jiménez-Peralta, Joan Carles, Cristina Suárez, Aleix Prat, Begona Mellado
Publikováno v:
Journal of Clinical Oncology. 40:5077-5077
5077 Background: TMPRSS2-ERG fusion has been associated with estrogen receptor (ER) signalling in prostate cancer (PC). The isoform beta of ER (ERβ), encoded by ESR2, is considered anti-proliferative and tumor-suppressive. In preclinical studies, ES
Autor:
Daniel Herrero Rivera, María Valle Enguix-Riego, María José Ortiz Gordillo, Juan Manuel Praena-Fernández, Eleonor Rivin del Campo, Jose María Nieto-Guerrero Gómez, Jon Cacicedo Fernández de Bobadilla, Jose Luis Lopez Guerra, Blas David Delgado, María del Carmen Fernandez Fernandez
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Background and purpose] Radiochemotherapy (RCT) success in lung cancer (LC) can be limited due to the onset of adverse effects in the adjacent normal tissue such as radiation-induced esophageal toxicity (RIET). Therefore, specific biomarkers to cust
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dac98de863fefc9327275496dce655a
http://hdl.handle.net/10261/205112
http://hdl.handle.net/10261/205112